Safety and efficacy of mycophenolate in COVID-19: a nonrandomised prospective study in western India

BACKGROUND: Antivirals and immunosuppressive agents are used with variable success in the treatment of COVID-19. Mycophenolate, an inhibitor of enzyme inosine monophosphate dehydrogenase, is an immunosuppressant used to prevent allograft rejection and other autoimmune diseases. Few laboratory studie...

Descripción completa

Detalles Bibliográficos
Autores principales: Sajgure, Atul, Kulkarni, Ajit, Joshi, Atul, Sajgure, Vasanti, Pathak, Vaishali, Melinkeri, Rashida, Pathak, Shilpa, Agrawal, Sumit, Naik, Manoj, Rajurkar, Milind, Sajgure, Ameya, Date, Girish
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874052/
https://www.ncbi.nlm.nih.gov/pubmed/36712812
http://dx.doi.org/10.1016/j.lansea.2023.100154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9874052/
https://www.ncbi.nlm.nih.gov/pubmed/36712812
http://dx.doi.org/10.1016/j.lansea.2023.100154

Ejemplares similares